You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allo-HCT

Showing 1 - 25 of 812
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Stem Cell Transplantation Trial in Ann Arbor (Bob's Red Mill®, Starch Placebo)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Bob's Red Mill®
  • Starch Placebo
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Dec 20, 2022

cGVHD Trial in Guanzhou (Belimumab (Benlysta))

Withdrawn
  • cGVHD
  • Belimumab (Benlysta)
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023

Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)

Recruiting
  • Relapsed Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 7, 2022

Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

Recruiting
  • Hematologic Malignancy
  • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
  • Duarte, California
    City of Hope
Oct 20, 2023

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)

Completed
Has Results
  • Adult Lymphoblastic Lymphoma
  • Birmingham, Alabama
    UAB Bone Marrow Transplantation and Cellular Therapy Program
Aug 23, 2022

Acute GVHD (Gvhd) Grade, Hematopoietic Cell Transplantation, Fecal Microbiota Transplant Trial in Boston (Fecal Microbiota

Recruiting
  • Acute Graft-Versus-Host Disease (Gvhd) Grade
  • +2 more
  • Fecal Microbiota Transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 29, 2021

Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

Completed
Has Results
  • Hematologic Malignancies
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Hospital
Dec 3, 2021

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

PD-1 Antibody, Mixed Chimerism Trial in Beijing (Toripalimab Injection)

Not yet recruiting
  • PD-1 Antibody
  • Mixed Chimerism
  • Toripalimab Injection
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jun 27, 2021

Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 14, 2022

Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

Recruiting
  • Mucopolysaccharidosis Disorders
  • +28 more
  • Stem Cell Transplantation
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 1, 2022

Resolving Inflammaging Allo HSCT Survivors in Personal Training

Completed
  • Allogeneic HCT Survivors
  • 10 Weeks of Strength Trailing
  • Group Nutrition Discussion: week 1, week 5 and week 10
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Mar 31, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)

Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CliniMacs TCR alpha-beta-Biotin system
  • Los Angeles, California
  • +9 more
Feb 10, 2022

Epidermolysis Bullosa Trial in Minneapolis (drug, radiation, procedure, biological)

Recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Jan 20, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Infusion of NEXI-001 T Cells
  • Duarte, California
  • +4 more
Feb 16, 2021

Blood Cancer, Refractory Immune Cytopenias Trial in United States (Isatuximab)

Not yet recruiting
  • Blood Cancer
  • Refractory Immune Cytopenias
  • Isatuximab
  • Basking Ridge, New Jersey
  • +6 more
May 15, 2023

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation Trial in Minneapolis (Fecal Microbiota Transplant (FMT),

Active, not recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Cell Transplantation
  • Fecal Microbiota Transplant (FMT)
  • Placebo
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Feb 16, 2022

Leukemia, Myeloid, MDS Trial in Gainesville (Lenalidomide)

Terminated
Has Results
  • Leukemia, Myeloid
  • Myelodysplastic Syndromes
  • Gainesville, Florida
    University of Florida Shands Cancer Center
Jan 13, 2020

Leukemia, Graft Failure Trial in Lille (eltrombopag)

Recruiting
  • Leukemia
  • Graft Failure
  • Lille, France
    Hôpital Claude Huriez, CHU
Aug 18, 2022

Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Personalized rATG (P-rATG)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 31, 2022

Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

Withdrawn
  • Prophylactic HQP1351 Therapy
  • Third Generation TKI
  • HQP1351( Olverembatinib dimesylate)
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023

B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Inotuzumab ozogamicin
  • +6 more
  • Nashville, Tennessee
  • +3 more
Aug 14, 2022